Physostigmine: Difference between revisions
(Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: ==Adult Dosing== ===Anticholinergic toxicity *0.5-2mg IV over 5min ==Pediatric Dosing== ==Special Populations==...") |
|||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===[[Anticholinergic toxicity]] | ===[[Anticholinergic toxicity]]=== | ||
*0.5-2mg IV over 5min | *0.5-2mg IV over 5min | ||
Revision as of 21:09, 23 May 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Anticholinergic toxicity
- 0.5-2mg IV over 5min
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
- Side effects: bradycardia, dysrhythmias, cholinergic excess
- Always have atropine at the bedside for bradycardia or cholinergic excess
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Onset of action: 15-20min